Like incretins, DPP-4 inhibitors also elicit beneficial effects against DR, with oral administration of sitagliptin preventing the pathological changes in the blood-retinal barrier in a rat model of type 2 diabetes [90]. Here, GCG is linked to type 2 diabetes mellitus.